Published • loading... • Updated
Editorial argues carotid stenting has reached “prime time” following CREST-2
Summary by Interventional News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Editorial argues carotid stenting has reached “prime time” following CREST-2
An editorial published in CVIR Endovascular argues that carotid artery stenting (CAS) should be considered a first-line treatment option for appropriately selected patients with both symptomatic and asymptomatic carotid artery stenosis, contending that recent evidence, led by the CREST-2 trial results, marks a turning point for the procedure. The article, led by Stefan Müller-Hülsbeck (Malteser Fördeklinikum St Katharina, Flensburg, Germany) and…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
